• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺素在肺内转化为三碘甲状腺原氨酸:肺癌组织与外周肺组织中Ⅰ型碘甲状腺原氨酸5′脱碘酶活性的比较。

The conversion of thyroxine to triiodothyronine in the lung: comparison of activity of type I iodothyronine 5' deiodinase in lung cancer with peripheral lung tissues.

作者信息

Wawrzynska L, Sakowicz A, Rudzinski P, Langfort R, Kurzyna M

机构信息

Department of Internal Chest Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

出版信息

Monaldi Arch Chest Dis. 2003 Apr-Jun;59(2):140-5.

PMID:14635503
Abstract

UNLABELLED

Triiodothyronine (T3) is the main active hormone, which is derived 20% from the thyroid gland and 80% from peripheral tissues. Thyroxin--5' deiodinases play a leading role in maintaining appropriate T3 concentrations in the different cells and organs: including the lung. The deiodinases present in pneumocytes were found to be localised in endoplasmatic reticulum. Aims of this study were: 1. To estimate activities of Type I and Type II iodothyronine 5' deiodinases (DI, DII) in two histological types of lung cancer. 2. To investigate possible differences in DI and DII activities between tumour tissue and peripheral lung tissue. 3. To study whether DI and DII activities are related to the extent of the disease process and grade of differentiation of lung cancer.

MATERIAL

We studied 44 patients undergoing thoracotomy due to lung cancer. Histologically: 23 pts--squamous cell cancer, 21 pts adenocarcinoma. In all patients both tumour and peripheral lung tissue were studied. DI activity was measured in pmol 1251- released from 125 IrT3/min/mg of proteins, DII activity--in fmol 125I- released from 125IT4/hour/mg of protein.

RESULTS

In most specimens DI and DII activities were observed. DI activity in specimens from lung peripheral tissue was: 3.3-58.3 pmol/min/mg of protein (mean 22.20) and in lung cancer tissue was: 2.0-44.7 pmol/min/mg of proteins (mean 13.3). DII activity in lung peripheral tissue ranged from 19 to 242 fmol/h/mg protein (mean 94.4) and in lung cancer ranged from 21 to 253 fmol/h/mg protein (mean 107.9).

CONCLUSIONS

  1. Conversion of T4 to T3 occurs also in the lung. 2. The activity of DI is statistically significantly lower, in lung cancer than in peripheral lung tissue (13.3 +/- 9.5 vs 22.20 +/- 13.4 pmol/min/mg protein) respectively, p < 0.001. 3. DII activity in lung is present and similar in peripheral lung and lung cancer tissue. 4. There is a non-significant trend for correlation of DI activity and grade of differentiation (G1-G3) of tumour tissue and stage of lung cancer. Abbreviations' list: T3--triiodothyronine, T4--thyroxine, FT4--free thyroxine, rT3--revers triiodothyronine TSII--Thyroid Stimulating Hormone Type I lodothyronine 5'deiodinase = type I 5'deiodinase = 5'DI = DI Type II Iodothyronine 5'deiodinase = typeII 5'deiodinase = 5'DII = DII E.S.S.--Euthyroid Sick Syndrome, hDII = human type II iodothyronine deiodinase HDII-b, hDII-c = two novel splice variants SCC--Squamous Cell Cancer, A--adenocarcinoma, BMI--Body Mass Index BSA--Bovine Standard Albumin, DTT-1,4 Dithio-L-treitol, PTU--Propylothiouracil TCA--Tricholoroacetic Acid, TNM--Tumour Nodule Metastases (class.) G1-G3-grade of differentiation, COPD--Chronic Obstructive Pulmonary Disease.
摘要

未标注

三碘甲状腺原氨酸(T3)是主要的活性激素,20%由甲状腺产生,80%来自外周组织。甲状腺素 - 5'脱碘酶在维持不同细胞和器官(包括肺)中适当的T3浓度方面起主导作用。发现肺细胞中的脱碘酶定位于内质网。本研究的目的是:1. 估计两种组织学类型肺癌中I型和II型碘甲状腺原氨酸5'脱碘酶(DI、DII)的活性。2. 研究肿瘤组织与外周肺组织中DI和DII活性的可能差异。3. 研究DI和DII活性是否与疾病进程程度和肺癌分化程度相关。

材料

我们研究了44例因肺癌接受开胸手术的患者。组织学上:23例为鳞状细胞癌,21例为腺癌。对所有患者的肿瘤组织和外周肺组织均进行了研究。DI活性以从125I-T3释放的125I的皮摩尔数/分钟/毫克蛋白质来测量,DII活性以从125I-T4释放的125I的飞摩尔数/小时/毫克蛋白质来测量。

结果

在大多数标本中观察到DI和DII活性。肺外周组织标本中的DI活性为:3.3 - 58.3皮摩尔/分钟/毫克蛋白质(平均22.20),肺癌组织中的DI活性为:2.0 - 44.7皮摩尔/分钟/毫克蛋白质(平均13.3)。肺外周组织中的DII活性范围为19至242飞摩尔/小时/毫克蛋白质(平均94.4),肺癌中的DII活性范围为21至253飞摩尔/小时/毫克蛋白质(平均107.9)。

结论

  1. T4向T3的转化也发生在肺中。2. 肺癌中DI的活性在统计学上显著低于外周肺组织(分别为13.3±9.5与22.20±13.4皮摩尔/分钟/毫克蛋白质),p<0.001。3. 肺中存在DII活性,且在外周肺组织和肺癌组织中相似。4. 肿瘤组织的DI活性与肺癌分化程度(G1 - G3)和分期之间存在不显著的相关趋势。缩写列表:T3 - 三碘甲状腺原氨酸;T4 - 甲状腺素;FT4 - 游离甲状腺素;rT3 - 反三碘甲状腺原氨酸;TSII - 促甲状腺激素;I型碘甲状腺原氨酸5'脱碘酶 = I型5'脱碘酶 = 5'DI = DI;II型碘甲状腺原氨酸5'脱碘酶 = II型5'脱碘酶 = 5'DII = DII;E.S.S. - 正常甲状腺病态综合征;hDII = 人II型碘甲状腺原氨酸脱碘酶;HDII - b、hDII - c = 两种新的剪接变体;SCC - 鳞状细胞癌;A - 腺癌;BMI - 体重指数;BSA - 牛标准白蛋白;DTT - 1,4 - 二硫苏糖醇;PTU - 丙硫氧嘧啶;TCA - 三氯乙酸;TNM - 肿瘤结节转移(分类);G1 - G3 - 分化程度;COPD - 慢性阻塞性肺疾病。

相似文献

1
The conversion of thyroxine to triiodothyronine in the lung: comparison of activity of type I iodothyronine 5' deiodinase in lung cancer with peripheral lung tissues.甲状腺素在肺内转化为三碘甲状腺原氨酸:肺癌组织与外周肺组织中Ⅰ型碘甲状腺原氨酸5′脱碘酶活性的比较。
Monaldi Arch Chest Dis. 2003 Apr-Jun;59(2):140-5.
2
Regulation of iodothyronine deiodinase activity as studied in thyroidectomized rats infused with thyroxine or triiodothyronine.在甲状腺切除并用甲状腺素或三碘甲状腺原氨酸灌注的大鼠中对碘甲状腺原氨酸脱碘酶活性的调节研究。
Endocrinology. 1997 Jun;138(6):2559-68. doi: 10.1210/endo.138.6.5212.
3
Defective stimulation of thyroxine 5'-deiodinase activity by cold exposure and norepinephrine in brown adipose tissue of monosodium glutamate-obese mice.在谷氨酸钠诱导肥胖小鼠的棕色脂肪组织中,冷暴露和去甲肾上腺素对甲状腺素5'-脱碘酶活性的刺激作用存在缺陷。
Horm Metab Res. 1997 Oct;29(10):496-500. doi: 10.1055/s-2007-979087.
4
The concentration of thyroid hormones and activities of iodothyronine deiodinases are altered in human brain gliomas.
Folia Neuropathol. 2004;42(2):67-73.
5
3,5-diiodo-L-thyronine stimulates type 1 5'deiodinase activity in rat anterior pituitaries in vivo and in reaggregate cultures and GH3 cells in vitro.3,5-二碘-L-甲状腺原氨酸在体内对大鼠垂体前叶、在重聚集培养物中以及在体外对GH3细胞均能刺激1型5'-脱碘酶活性。
Endocrinology. 1997 Aug;138(8):3242-8. doi: 10.1210/endo.138.8.5333.
6
Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus.禁食诱导的大鼠下丘脑II型碘甲状腺原氨酸脱碘酶活性和信使核糖核酸水平升高不会被甲状腺素逆转。
Endocrinology. 1998 Jun;139(6):2879-84. doi: 10.1210/endo.139.6.6062.
7
Iodothyronine deiodinase activities in FRTL5 cells: predominance of type I 5'-deiodinase.FRTL5细胞中的碘甲状腺原氨酸脱碘酶活性:I型5'-脱碘酶占主导。
Endocrinology. 1990 Jun;126(6):3059-68. doi: 10.1210/endo-126-6-3059.
8
Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines.维甲酸可刺激人甲状腺滤泡癌细胞系中I型碘甲状腺原氨酸5'-脱碘酶的活性。
J Clin Endocrinol Metab. 1994 Sep;79(3):791-8. doi: 10.1210/jcem.79.3.8077363.
9
Sequential deiodination of thyroxine in human thyroid gland.甲状腺素在人体甲状腺中的顺序脱碘作用。
J Clin Endocrinol Metab. 1982 Nov;55(5):890-6. doi: 10.1210/jcem-55-5-890.
10
Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system.人中枢神经系统中酚类和酪氨酰环甲状腺素脱碘作用及甲状腺激素浓度
J Clin Endocrinol Metab. 1996 Jun;81(6):2179-85. doi: 10.1210/jcem.81.6.8964848.

引用本文的文献

1
Progressive Cachexia: Tuberculosis, Cancer, or Thyrotoxicosis? Disease-Directed Therapy and Atypical Courses of Autoimmune and Malignant Thyroid Diseases in a High Specialization Era: Case-Control Study with a Critical Literature Review.进行性恶病质:结核病、癌症还是甲状腺毒症?在高度专业化时代针对疾病的治疗以及自身免疫性和恶性甲状腺疾病的非典型病程:一项病例对照研究及批判性文献综述
Biomedicines. 2024 Nov 28;12(12):2722. doi: 10.3390/biomedicines12122722.
2
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer.硒酶 I 型甲状腺素脱碘酶:卵巢癌中的一种新的肿瘤抑制因子。
Mol Oncol. 2024 Sep;18(9):2298-2313. doi: 10.1002/1878-0261.13612. Epub 2024 Mar 1.
3
Deiodinases and Cancer.
脱碘酶与癌症。
Endocrinology. 2021 Apr 1;162(4). doi: 10.1210/endocr/bqab016.
4
Deiodinases and their intricate role in thyroid hormone homeostasis.脱碘酶及其在甲状腺激素动态平衡中的复杂作用。
Nat Rev Endocrinol. 2019 Aug;15(8):479-488. doi: 10.1038/s41574-019-0218-2.
5
Paradigms of Dynamic Control of Thyroid Hormone Signaling.动态控制甲状腺激素信号的范式。
Endocr Rev. 2019 Aug 1;40(4):1000-1047. doi: 10.1210/er.2018-00275.
6
Enzymatic activity of type 1 iodothyronine deiodinase in selected liver tumors.1 型碘甲状腺原氨酸脱碘酶在选定肝肿瘤中的酶活性。
Arch Med Sci. 2014 Aug 29;10(4):801-5. doi: 10.5114/aoms.2013.34323. Epub 2013 Aug 20.
7
Levothyroxine and lung cancer in females: the importance of oxidative stress.左旋甲状腺素与女性肺癌:氧化应激的重要性。
Reprod Biol Endocrinol. 2013 Aug 8;11:75. doi: 10.1186/1477-7827-11-75.
8
Thyroid hormone deiodinases and cancer.甲状腺激素脱碘酶与癌症。
Front Endocrinol (Lausanne). 2012 Jun 1;3:74. doi: 10.3389/fendo.2012.00074. eCollection 2012.
9
Iodothyronine deiodinases and cancer.碘甲状腺原氨酸脱碘酶与癌症。
J Endocrinol Invest. 2011 Oct;34(9):716-28. doi: 10.3275/7754. Epub 2011 May 27.
10
The enzymatic activity of type 1 iodothyronine deiodinase (D1) is low in liver hemangioma: a preliminary study.肝血管瘤中 1 型碘甲状腺原氨酸脱碘酶(D1)的酶活性较低:一项初步研究。
Arch Immunol Ther Exp (Warsz). 2010 Feb;58(1):77-80. doi: 10.1007/s00005-009-0056-3. Epub 2010 Jan 5.